Illumina

Oncology
ESMO 2024 Dr Magda Meissner interview with Nicole Raleigh

ESMO 2024 – Magda Meissner

In our penultimate video from ESMO 2024, pharmaphorum spoke with Dr Magda Meissner, consultant medical oncologist at the Velindre Cancer Centre and project lead for QuicDNA, about how a sim

Oncology
Sven Schaffer and Nicole Raleigh interview at ESMO

ESMO 2024 - Sven Schaffer

The European Society for Medical Oncology (ESMO) 2024 meeting was a well-attended affair at the sprawling Fira Gran Via centre in Barcelona.

News
Illumina avoids hefty EU fine over Grail merger

Illumina avoids hefty EU fine over Grail merger

The top court in the EU has ruled that the European Commission exceeded its authority in its investigation of the $8 billion merger between Illumina and Grail, albeit too late to halt the f

Market Access
King chess piece

Illumina-Grail saga ends with divestment

In a case that had been closely watched across multiple industries, Illumina chose to divest Grail in the light of legal action from the European Commission and the US Federal Trade Commiss